ADAG · NASDAQ · Biotechnology

Adagene (ADR)

Develops antibody cancer immunotherapies and licenses tumor-activated masking technology.

$3.68
After-hours close+0.02 (+0.55%)
At close$3.66(−6.15%)

Breakdown13F · Form 4

Institutions 8.77%Insiders

Shares outstanding 37.65M · Float 26.99M · 71.7% free float

Insiders — filings are in the shares behind the receipt.

This listing is a depositary receipt and the Form 4 positions here are filed in the shares behind it, a different unit from the share count and in a ratio the filings never state, so no insider percentage is shown.

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
HAN 2020 Irrevocable Trust9.39M11.20%13DJun 8, 2026
Janus Henderson Group PLC6.67M10.10%13GMay 7, 2026
Smith Vincent C5.10M8.70%13GJan 29, 2026
WuXi PharmaTech Healthcare Fund I L.P.3.49M5.90%13GMay 15, 2026
Chernett Jorey2.39M5.10%13GMar 18, 2026

Institutions13F, as of Mar 31, 2026

25 holders · 3.30M shares · 11 new positions · 14 increased · 6 reduced · 3 closed

HolderShares% outstandingChg q/qFiled
SC China Holding Ltd1.34M3.57%0May 15, 2026
Exome Asset Management LLC736.8K1.96%−323.4KMay 15, 2026
Ameriprise Financial Inc607.9K1.61%+607.9KnewJul 17, 2026
Mill Creek Capital Advisors, LLC199.6K0.53%0May 14, 2026
Morgan Stanley66.1K0.18%−9.5KMay 15, 2026
Invesco Ltd.47.1K0.13%+47.1KnewMay 12, 2026
Smartharvest Portfolios, LLC40.3K0.11%+1.5KApr 21, 2026
Kamunting Street Capital Management, L.P.38.1K0.10%−88.0KMay 15, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
HAN 2020 Irrevocable Trustincl. Peter Luo11.20%9.39M13DJun 8, 2026
Janus Henderson Group PLC10.10%6.67M13GMay 7, 2026
Smith Vincent C8.70%5.10M13GJan 29, 2026
WuXi PharmaTech Healthcare Fund I L.P.5.90%3.49M13GMay 15, 2026
Chernett Jorey5.10%2.39M13GMar 18, 2026

InsidersForm 4

InsiderRoleSharesFiled
Peter Luodirector, officer: Chief Executive Officer68.2KAug 6, 2026
Cuong V. Dodirector2.0KAug 18, 2026

7 positions are filed in the unlisted share unit (873.6K shares), which no share count here divides

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 14, 2026
Cuong V. Dodirector
Purchase2,000$3.752,000
Aug 4, 2026
Peter Luodirector, officer: Chief Executive Officer
Purchase22,966$3.6567,966
Aug 5, 2026
Peter Luodirector, officer: Chief Executive Officer
Purchase279$3.6568,245

CongressHouse and Senate disclosures

Not reported.